The FDA Releases a New Webpage During Covid-19 Outbreak
|The U.S. Food and Drug Administration (FDA) released a new webpage of information to help address questions patients and caregivers may have about FDA-regulated medical products (drugs, biologics, and devices) during the coronavirus (COVID-19) outbreak. The webpage is a source of information for patients during this time of crisis. Visitors to the page can find information on:
Please visit the webpage at https://www.fda.gov/patients/coronavirus-disease-2019-covid-19-resources-patients. For additional questions you may have, please contact the FDA’s Patient Affairs Staff at 301-796-8460 or email email@example.com.
Other Patient Resources:
Questions and Answers for Patients About Clinical Trials During COVID-19 Outbreak
Patient Affairs Staff (PAS)
Want to learn more about how PAS works to improve, expand and maintain communication with patients, check out the Patient Affairs Staff webpage, email us at PatientAffairs@fda.gov or follow us on Twitter @FDAPatientInfo.
Should you wish to opt-out of future communications from the Patient Affairs Staff, please send an email to PatientAffairs@fda.gov.